Skip to main content

Security report for biosimilarscanada.ca

Biosimilars Canada · Healthcare · Canada

High risk. 8 critical or high findings in Network security, Security headers and 2 other checks.

Security score

49/100

Risk levelHigh

0–100, higher is better. How it is calculated

Biosimilars Canada is a national industry association dedicated to representing and advocating for the biosimilar medicines sector in Canada. The organization focuses on educating stakeholders including patients, healthcare providers, employers, and policymakers about the safety, efficacy, and benefits of biosimilars. Their market position is that of a trusted national voice promoting biosimilar adoption and policy support. The website reflects a professional and consistent brand image with clear navigation and relevant content tailored to their target audience. Technically, the website is built on WordPress using Elementor and JupiterX theme, leveraging modern SEO and performance optimization plugins such as Yoast SEO and WP Rocket. The site is mobile optimized and uses Google Analytics and Tag Manager for tracking. Hosting and domain registration are stable and appropriate for the organization's profile. From a security perspective, the site uses HTTPS with a good SSL configuration and domain status protections. However, DNSSEC is not enabled, and no explicit security or incident response policies are published on the site. Cookie consent mechanisms are absent despite the use of tracking scripts, indicating a gap in privacy compliance. No critical vulnerabilities or suspicious indicators were found. Overall, the website presents a low-risk profile with good business credibility and technical implementation. Strategic improvements in privacy compliance and security headers would enhance the security posture and trustworthiness further.

Scanned

NIS2 and GDPR posture

GDPR outside view
53/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

8 findings rated critical or high. Fix these first.

  1. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • Critical

      Critical Service Exposed: MySQL

      Port 3306 (MySQL) is publicly accessible - MySQL - Database server

      What to do: Immediately restrict access to MySQL using firewall or VPN

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  3. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

Need hands-on remediation? Email guard@offseq.com

Keep watching biosimilarscanada.ca

This scan found 25 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
15
Email security
85
DNS health
85
Network security
0
GDPR outside view
53
Average
50
After the cap
49

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet · found on this site
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Biosimilars Canada operates as an important healthcare industry association in Canada, focusing on biosimilar medicines. Their business model centers on advocacy, education, and stakeholder engagement rather than commercial sales. They target healthcare stakeholders, patients, employers, and policymakers, aiming to influence biosimilar adoption and reimbursement policies. The organization maintains partnerships with related industry groups such as Canadian Generics and IGBA Medicines. The website content and structure support their mission with educational resources, news updates, and campaign information. Growth indicators include recent news releases and active social media channels. The association is relatively small but well-established since 2015, with a clear national focus.

Security posture

The website demonstrates a moderate security maturity level with HTTPS enforced and domain status protections that prevent unauthorized domain changes. The absence of DNSSEC is a minor security gap that could be addressed to improve domain integrity. No security headers were detected, and there is no published security policy or incident response information, which limits transparency and preparedness indicators. The use of third-party tracking scripts without a cookie consent mechanism suggests incomplete privacy compliance. No exposed sensitive data or vulnerable libraries were identified. Overall, the security posture is adequate for an informational website but could benefit from enhanced security controls and privacy practices.

Recommendations

  1. Enable DNSSEC on the domain to strengthen DNS security and prevent spoofing.
  2. Implement and display a comprehensive cookie consent mechanism to comply with privacy regulations.
  3. Add security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security to improve browser security.
  4. Publish a clear security policy and incident response plan accessible on the website to enhance transparency and trust.
  5. Regularly review and update third-party scripts and plugins to mitigate potential vulnerabilities.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Biosimilars Canada
Description
Biosimilars Canada is a national association representing the biosimilar medicines industry in Canada. They provide leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines, and advocate for policies supporting timely approval, reimbursement, market acceptance, and expanded use.
Key services
Education about biosimilars, Advocacy for biosimilar policies, Information resources for patients and employers
Content quality
good
Branding
consistent

Technology

Stack
WordPress, Elementor, JupiterX theme, Yoast SEO, WP Rocket, Google Tag Manager, jQuery
Frameworks
Elementor, Yoast SEO
Platforms
WordPress
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
75/100
Good practices seen
  • HTTPS enforced
  • Domain status includes clientDeleteProhibited, clientTransferProhibited, clientUpdateProhibited

Analytics and tracking

Services
Google Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
basic

Advertising

Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured.
  2. Content is focused on biosimilar medicines education and advocacy.
  3. No signs of malicious or suspicious activity.
  4. No explicit security or incident response policies published.
  5. No cookie consent mechanism detected despite use of tracking scripts.
  6. Social media presence is active and linked in footer.
  7. WHOIS privacy protection is used but justified.
  8. DNSSEC is not enabled, which is a minor security gap.
Technical notes

Notes

The website is built on a modern WordPress platform using Elementor page builder and the JupiterX theme, supported by performance optimization plugins like WP Rocket and SEO tools like Yoast SEO. It uses Google Tag Manager and Google Analytics for tracking user interactions. The site is mobile responsive with good navigation and structured content. Hosting details are limited but the registrar is reputable. Performance is moderate with some deferred scripts and lazy loading implemented. Accessibility is basic but present. Technical risks are low, though the lack of DNSSEC and security headers represent areas for improvement. Overall, the technical infrastructure supports the business goals effectively with room for security and privacy enhancements.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with biosimilarscanada.ca. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review biosimilarscanada.ca.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.